References
- Amirkhanov, V., Rauf, A., Ben Hadda, T., Ovchynnikov, V., Trush, V., Saleem, M., Raza, M., Rehman, T., Zgou, H., Shaheen, U., & Farghaly, T. (2019). Pharmacophores modeling in terms of prediction of theoretical physicochemical properties and verification by experimental correlations of carbacylamidophosphates (CAPh) and sulfanylamidophosphates (SAPh) tested as new carbonic anhydrase inhibitors. Mini-Reviews in Medicinal Chemistry, 19(12), 1015–1027. https://doi.org/10.2174/1389557519666190222172757
- Bäck, M., Johansson, P.-O., Wångsell, F., Thorstensson, F., Kvarnström, I., Ayesa, S., Wähling, H., Pelcman, M., Jansson, K., Lindström, S., Wallberg, H., Classon, B., Rydergård, C., Vrang, L., Hamelink, E., Hallberg, A., Rosenquist, S., & Samuelsson, B. (2007). Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs. Bioorganic & Medicinal Chemistry, 15(22), 7184–7202. https://doi.org/10.1016/j.bmc.2007.07.027
- Badshah, S. L., Ahmad, N., Ur Rehman, A., Khan, K., Ullah, A., Alsayari, A., Muhsinah, A. B., & N Mabkhot, Y. (2019). Molecular docking and simulation of Zika virus NS3 helicase. BMC Chemistry, 13(1), 67. https://doi.org/10.1186/s13065-019-0582-y
- Bartenschlager, R. (2013). Hepatitis C virus: From molecular virology to antiviral therapy. Current Topics in Microbiology and Immunology, Springer-Verlag. https://doi.org/10.1007/978-3-642-27340-7.
- Bechlem, K., Aissaoui, M., Belhani, B., Rachedi, K. O., Bouacida, S., Bahadi, R., Djouad, S. E., Mansour, R. B., Bouaziz, M., Almalki, F., Ben Hadda, T., & Berredjem, M. (2020). Synthesis, X-ray crystallographic study and molecular docking of new a-sulfamidophosphonates: POM analyses of their cytotoxic activity. Journal of Molecular Structure, 1210, 127990–127997. https://doi.org/10.1016/j.molstruc.2020.127990
- Becke, A. D. (1993). Density-functional thermochemistry. III. The role of exact exchange. Journal of Chemical Physics, 98(7), 5648–5652. https://doi.org/10.1063/1.464913
- Ben Hadda, T., Fergoug, T., Warad, I., Masand, V., & Sheikh, J. (2013a). POM as a quick bioinformatic platform to select flavonoids and their metabolites as potential and efficient HIV-1 integrase inhibitors. Research on Chemical Intermediates, 39(3), 1227–1244. https://doi.org/10.1007/s11164-012-0679-6
- Ben Hadda, T., Kerbal, A., Bennani, B., Houari, G. A., Daoudi, M., Leite, A. C. L., Masand, V. H., Jawarkar, R. D., & Charrouf, Z. (2013b). Molecular drug design, synthesis and pharmacophore site identification of spiroheterocyclic compounds: Trypanosoma crusi inhibiting studies. Medicinal Chemistry Research, 22(1), 57–69. https://doi.org/10.1007/s00044-012-0010-5
- Ben Hadda, T., Srivastava, S., Das, B., Zamora, H. S., Shaheen, U., Bader, A., & Naseer, M. M. (2014). POM analyses of antimicrobial activity of some 2,3-armed 4,5,6,7-tetrahydro-1-benzothiophenes: Favourable and unfavourable physico-chemical parameters in design of antibacterial and mycolytic agents. Medicinal Chemistry Research, 23(2), 995–1003. https://doi.org/10.1007/s00044-013-0707-0
- Brintzinger, H. H., Prosenc, M. H., Schaper, F., Weeber, A., & Wieser, U. (1999). Alternative force field models for ansa-zirconocene complexes-vibrational and structural studies on Me2Si-bridged and tert-butyl-substituted representatives. Journal of Molecular Structure, 485–486, 409–419. https://doi.org/10.1016/S0022-2860(99)00184-2
- Chohan, Z. H., Sumrra, S. H., Youssoufi, M. H., & Ben Hadda, T. (2010a). Design and synthesis of triazole Schiff bases and their oxovanadium(IV) complexes as antimicrobial agents. Journal of Coordination Chemistry, 63(22), 3981–3998. https://doi.org/10.1080/00958972.2010.523783
- Chohan, Z. H., Sumrra, S. H., Youssoufi, M. H., & Hadda, T. B. (2010b). Metal based biologically active compounds: Design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes. European Journal of Medicinal Chemistry, 45(7), 2739–2747. https://doi.org/10.1016/j.ejmech.2010.02.053
- Deppmeier, J. B., Driessen, A., Hehre, T. S., Hehre, W. J., Johnson, J. A., Klunzinger, P. E., & Pople, J. A. (2002). SPARTAN 02. Wave function Inc.
- Francl, M. M., Pietro, W. J., Hehre, W. J., Binkley, J. S., Gordon, M. S., De Frees, D. J., & Pople, J. A. (1982). Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second-row elements. Journal of Chemical Physics, 77(7), 3654–3665. https://doi.org/10.1063/1.444267
- Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A., Bloino, J., Janesko, B. J., Gomperts, R., Mennucci, B., Hratchian, H. P., Ortiz, J. V., … Fox, J. D. (2009). Gaussian 09, Revision A.02. Gaussian 09 Inc.
- Halfon, P., Locarnini, S. (2011). Hepatitis C virus resistance to protease inhibitors. Journal of Hepatology, 55(1), 192–206. https://doi.org/10.1016/j.jhep.2011.01.011
- Huang, N., Kalyanaraman, C., Bernacki, K., & Jacobson, M. P. (2006). Molecular mechanics methods for predicting protein-ligand binding. Physical Chemistry Chemical Physics: PCCP, 8(44), 5166–5177. https://doi.org/10.1039/b608269f
- Jogi, P. S., Meshram, J., Sheikh, J., & Ben Hadda, T. (2013). Synthesis, biopharmaceutical characterization, and antimicrobial study of novel azo dyes of 7-hydroxy-4-methylcoumarin. Medicinal Chemistry Research, 22(9), 4202–4210. https://doi.org/10.1007/s00044-012-0421-3
- Jolliffe, I. T. (2002). Principal Component Analysis. 2nd Edition. Springer, New York.
- Lafridi, H., Zaki, H., Zgou, H., & Bouachrine, M. (2018). 2D QSAR study of imidazothiazole-propenones derivatives as potential anticancer agents by DFT-QSAR models. Der Pharma Chemica, 10, 33–42.
- Mabkhot, Y. N., Al-Showiman, S. S., Barakat, A., Soliman, S. M., Kheder, N. A., Alharbi, M. M., Asayari, A., Muhsinah, A. B., Ullah, A., & Badshah, S. L. (2019). Computational studies of 2-(4-oxo-3-phenylthiazolidin-2-ylidene)malononitrile. BMC Chemistry, 13(1), 25. https://doi.org/10.1186/s13065-019-0542-6
- Mabkhot, Y. N., Arfan, M., Zgou, H., Genc, Z. K., Genc, M., Rauf, A., Bawazeer, S., & Ben Hadda, T. (2016). How to improve antifungal bioactivity: POM and DFT study of some chiral amides derivatives of diacetyl-Ltartaric acid and amines. Research on Chemical Intermediates, 42(12), 8055–8068. https://doi.org/10.1007/s11164-016-2578-8
- McGivern, D. R., Masaki, T., Lovell, W., Hamlett, C., Saalau-Bethell, S., & Graham, B. (2015). Protease inhibitors block multiple functions of the NS3/4A protease-helicase during the hepatitis C virus life cycle. Journal of Virology, 89(10), 5362–5370. https://doi.org/10.1128/JVI.03188-14
- Melnikova, I. (2011). Hepatitis C—pipeline update. Nat Rev Drug Discov, 10(2), 93–94. https://doi.org/10.1038/nrd3361
- MOE. (2009). Molecular Operating Environment. Scientific Computing & Instrumentation. Vol. 2009.10 Re.
- Morikawa, K., Lange, C. M., Gouttenoire, J., Meylan, E., Brass, V., Penin, F., & Moradpour, D. (2011). Nonstructural protein 3-4A: The Swiss army knife of hepatitis C virus. Journal of Viral Hepatitis, 18(5), 305–315. https://doi.org/10.1111/j.1365-2893.2011.01451.x
- Nasir, A., Syed, L. B., Asharef, U. R., Akhtar, M., & Khalid, K. (2021). Structural insights into the Zika virus NS1 protein inhibition using a computational approach. Journal of Biomolecular Structure and Dynamics, 39(8), 3004–3011. https://doi.org/10.1080/07391102.2020.1759453
- Parr, R. G., Pearson, R. G. (1983). Absolute hardness: Companion parameter to absolute electronegativity. Journal of the American Chemical Society, 105(26), 7512–7516. https://doi.org/10.1021/ja00364a005
- Rachedi, K. O., Ouk, S. T., Bahadi, R., Bouzina, A., Djouad, S. E., Bechlem, K., Zerrouki, R., Ben Hadda, T., Almalki, F., & Berredjem, M. (2019). Synthesis, DFT and POM analyses of cytotoxicity activity of α-amidophosphonates derivatives: Identification of potential antiviral O,O-pharmacophore site. Journal of Molecular Structure, 1197, 196–203. https://doi.org/10.1016/j.molstruc.2019.07.053
- Schiering, N., D’Arcy, A., Villard, F., Simic, O., Kamke, M., Monnet, G., Hassiepen, U., Svergun, D. I., Pulfer, R., Eder, J., Raman, P., & Bodendorf, U. (2011). A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. Proceedings of the National Academy of Sciences of the United States of America, 108(52), 21052–21056. https://doi.org/10.1073/pnas.1110534108
- Scola, P. M., Wang, A. X., Good, A. C., Sun, L.-Q., Combrink, K. D., Campbell, J. A., Chen, J., Tu, Y., Sin, N., Venables, B. L., Sit, S.-Y., Chen, Y., Cocuzza, A., Bilder, D. M., D’Andrea, S., Zheng, B., Hewawasam, P., Ding, M., Thuring, J., … McPhee, F. (2014). Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection. Journal of Medicinal Chemistry, 57(5), 1708–1729. https://doi.org/10.1021/jm401840s
- Senet, P. (1997). Chemical hardnesses of atoms and molecules from frontier orbitals. Chemical Physics Letters, 275(5–6), 527–532. https://doi.org/10.1016/S0009-2614(97)00799-9
- Sheikh, J., Juneja, H., Ingle, V., Ali, P., & Ben Hadda, T. (2013). Synthesis and in vitro biology of Co(II), Ni(II), Cu(II) and Zinc(II) complexes of functionalized beta-diketone bearing energy buried potential antibacterial and antiviral O,O pharmacophore sites. Journal of Saudi Chemical Society, 17(3), 269–276. https://doi.org/10.1016/j.jscs.2011.04.004
- Sheikh, J., Parvez, A., Juneja, H., Ingle, V., Chohan, Z., Youssoufi, M., & Ben Hadda, T. (2011). Synthesis, biopharmaceutical characterization, antimicrobial and antioxidant activities of 1-(4'-O-β-D-glucopyranosyloxy-2'-hydroxyphenyl)-3-aryl-propane-1,3-diones. European Journal of Medicinal Chemistry, 46 (4), 1390–1399. https://doi.org/10.1016/j.ejmech.2011.01.068
- Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., Strader, D. B., & Trotter, H. T. (2009). National Institutes of Health consensus development conference statement: Management of hepatitis B. Annals of Internal Medicine, 150(2), 104–110. https://doi.org/10.1002/hep.22946.
- Stauber, R. E., Kessler, H. H. (2008). Drugs in development for hepatitis C. Drugs, 68(10), 1347–1359. https://doi.org/10.2165/00003495-200868100-00002.
- Tun, W., Vu, L., Adebajo, S. B., Abiodun, L., Sheehy, M., Karlyn, A., Njab, J., Ahonsi, B., Issa, K. B., & Idogho, O. (2013). Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria. International Journal of STD & AIDS, 24(8), 619–625. https://doi.org/10.1177/0956462413477553
- Wadood, A., Riaz, M., Uddin, R., & Ul-Haq, Z. (2014). In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening. PLoS One, 9(2), e89109. https://doi.org/10.1371/journal.pone.0089109
- Wei, D. Q., Ma, Y., Cho, W. C., Xu, Q., & Zhou, F. (2017). Translational bioinformatics and its application. Springer. https://doi.org/10.1007/978-94-024-1045-7.
- XLSTAT Software. (2009). XLSTAT Company.